MedTrace Logo

Impact of Exclusive Use of Low Nicotine Cigarettes on Compensatory Smoking

NCT03311646 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2020-01-28

Study results available
· View outcomes & findings →

Summary

Smoking is the leading cause of preventable death in the United States. An FDA-mandated reduction in the nicotine content of cigarettes might reduce the health burden of tobacco by reducing the prevalence of smoking. The proposed project will test the impact of nicotine reduction on smoking behavior and smoke exposure in a setting where participants are restricted from using their usual brand cigarettes.

Conditions

  • Smoking

Interventions

OTHER

Normal nicotine content cigarettes (NNC, Baseline)

Participants will exclusively smoke research cigarettes that have a normal nicotine content for five days/four nights while staying in a hotel.

OTHER

Very low nicotine content (VLNC)

Participants will exclusively smoke research cigarettes that have a very low nicotine content for five days/four nights while staying in a hotel.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Tracy Smith, PhD · Medical University of South Carolina

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-15
Primary Completion
2018-11-15
Completion
2018-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03311646 on ClinicalTrials.gov